Bristol Haematology and Oncology Centre — Bristol

Public research footprint of Bristol Haematology and Oncology Centre, compiled from the ClinicalTrials.gov public registry.

175

Registered studies

Active

Recruiting now

Completed

Stopped or withdrawn

Most-studied conditions

Multiple Myeloma · Hodgkin Lymphoma · Metastatic Castration-sensitive Prostate Cancer · Chronic Lymphocytic Leukemia

Recently updated registry entries

NCT07053800 — Obe-cel in Severe, Refractory Systemic Lupus Erythematosus (SLE) With Active Lupus… (Recruiting)
NCT03108495 — Study of LN-145, Autologous Tumor Infiltrating Lymphocytes in the Treatment of Patients… (Terminated)
NCT04728893 — Efficacy and Safety of Nemtabrutinib (MK-1026) in Participants With Hematologic… (Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at Bristol Haematology and Oncology Centre?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 02, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.